468 related articles for article (PubMed ID: 28640109)
1. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
Nakamura K; Inokuchi R; Daidoji H; Naraba H; Sonoo T; Hashimoto H; Tokunaga K; Hiruma T; Doi K; Morimura N
Medicine (Baltimore); 2017 Jun; 96(25):e7206. PubMed ID: 28640109
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial.
Nakamura K; Marushima A; Takahashi Y; Mochizuki M; Kimura A; Fukuda Y; Asami M; Nakamoto H; Egawa S; Kaneko J; Unemoto K; Kondo Y; Yonekawa C; Uchida M; Hoshiyama E; Yamada T; Maruo K; Ishikawa E; Matsumaru Y; Inoue Y;
J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):42-48. PubMed ID: 36207063
[TBL] [Abstract][Full Text] [Related]
3. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study.
Gujjar AR; Nandhagopal R; Jacob PC; Al-Hashim A; Al-Amrani K; Ganguly SS; Al-Asmi A
Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211
[TBL] [Abstract][Full Text] [Related]
4. Intravenous levetiracetam treatment in status epilepticus: A prospective study.
Atmaca MM; Orhan EK; Bebek N; Gurses C
Epilepsy Res; 2015 Aug; 114():13-22. PubMed ID: 26088881
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam versus phenytoin in management of status epilepticus.
Chakravarthi S; Goyal MK; Modi M; Bhalla A; Singh P
J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652
[TBL] [Abstract][Full Text] [Related]
6. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
Besli GE; Yuksel Karatoprak E; Yilmaz S
Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial.
Nakamura K; Marushima A; Takahashi Y; Kimura A; Asami M; Egawa S; Kaneko J; Kondo Y; Yonekawa C; Hoshiyama E; Yamada T; Maruo K; Inoue Y;
Trials; 2021 May; 22(1):317. PubMed ID: 33934714
[TBL] [Abstract][Full Text] [Related]
9. Efficacy Of Levetiracetam Versus Phenytoin As A Second-Line Antiepileptic Drug In The Management Of Benzodiazepine-Refractory Status Epilepticus Among Children.
Naeem B; Ashfaq M; Qureshi MA
J Ayub Med Coll Abbottabad; 2023; 35(3):410-414. PubMed ID: 38404082
[TBL] [Abstract][Full Text] [Related]
10. Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.
Hardy BT; Patterson EE; Cloyd JM; Hardy RM; Leppik IE
J Vet Intern Med; 2012; 26(2):334-40. PubMed ID: 22295898
[TBL] [Abstract][Full Text] [Related]
11. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures.
Abend NS; Monk HM; Licht DJ; Dlugos DJ
Pediatr Crit Care Med; 2009 Jul; 10(4):505-10. PubMed ID: 19325512
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
[TBL] [Abstract][Full Text] [Related]
13. Fosphenytoin vs. continuous midazolam for pediatric febrile status epilepticus.
Nishiyama M; Nagase H; Tomioka K; Tanaka T; Yamaguchi H; Ishida Y; Toyoshima D; Fujita K; Maruyama A; Kurosawa H; Uetani Y; Nozu K; Taniguchi-Ikeda M; Morioka I; Takada S; Iijima K
Brain Dev; 2018 Nov; 40(10):884-890. PubMed ID: 30144969
[TBL] [Abstract][Full Text] [Related]
14. Intravenous levetiracetam as treatment for status epilepticus.
Berning S; Boesebeck F; van Baalen A; Kellinghaus C
J Neurol; 2009 Oct; 256(10):1634-42. PubMed ID: 19458986
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
Köle MT; Sager SG; Zeynel H; Çağ Y; Akın Y
Childs Nerv Syst; 2022 Jul; 38(7):1357-1364. PubMed ID: 35501510
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.
Mazarati AM; Baldwin R; Klitgaard H; Matagne A; Wasterlain CG
Epilepsy Res; 2004 Feb; 58(2-3):167-74. PubMed ID: 15120747
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant therapy for status epilepticus.
Prasad M; Krishnan PR; Sequeira R; Al-Roomi K
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD003723. PubMed ID: 25207925
[TBL] [Abstract][Full Text] [Related]
18. Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial.
Lyttle MD; Gamble C; Messahel S; Hickey H; Iyer A; Woolfall K; Humphreys A; Bacon NEA; Roper L; Babl FE; Dalziel SR; Ryan M; Appleton RE;
Trials; 2017 Jun; 18(1):283. PubMed ID: 28629473
[TBL] [Abstract][Full Text] [Related]
19. Intravenous levetiracetam in clinical practice--Results from an independent registry.
Lang N; Esser W; Evers S; Kellinghaus C; Nguento A; Schlegel U; Gaida B; Gburek-Augustat J; Altenmüller DM; Burghaus L; Hoffmann F; Fiedler B; Bast T; Rehfeld T; Happe S; Seitz RJ; Boor R; Stephani U
Seizure; 2015 Jul; 29():109-13. PubMed ID: 26076852
[TBL] [Abstract][Full Text] [Related]
20. Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
Sathe AG; Mishra U; Ivaturi V; Brundage RC; Cloyd JC; Elm JJ; Chamberlain JM; Silbergleit R; Kapur J; Lowenstein DH; Shinnar S; Cock HR; Fountain NB; Babcock L; Coles LD
J Clin Pharmacol; 2021 Jun; 61(6):763-768. PubMed ID: 33336359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
